|
2023
|
Invention
|
Opioid receptor modulator dosage formulations. Abuse deterrent solid dosage formulations containi... |
|
2021
|
Invention
|
Forms of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazol-2-y... |
|
2020
|
Invention
|
Opioid receptor modulator dosage formulations.
Abuse deterrent solid dosage formulations contain... |
|
2019
|
Invention
|
Polymorphs of 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-phenyl-1h-imidazo... |
|
2017
|
Invention
|
Methods of treatment using eluxadoline. The present invention relates to a novel use of eluxadoli... |
|
2016
|
Invention
|
Crystals and process of making 5-({[2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(4-... |
|
|
P/S
|
Pharmaceutical preparations and substances. |
|
|
P/S
|
Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome. |
|
|
Invention
|
Process for the preparation of intermediates useful in the synthesis of eluxadoline. The inventio... |
|
2015
|
P/S
|
Medicinal pharmaceutical product to treat Diarrhea Predominant Irritable Bowel Syndrome; Pharmace... |
|
|
P/S
|
Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome |
|
|
P/S
|
Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome |
|
2014
|
P/S
|
Pharmaceutical preparations and substances, none being for the diagnosis and/or treatment of diab... |
|
|
P/S
|
[ Oral, Transdermal, Injectable and Intravaginal Contraceptives; Hormone replacement therapy prep... |
|
2013
|
P/S
|
Pharmaceutical preparations for the treatment of premature ejaculation, erectile dysfunction, sex... |
|
|
Invention
|
Crystals and process of making 5-({(2-amino-3-(4-carbamoyl-2,6-dimethyl-phenyl)-propionyl]-[1-(-4... |
|
2010
|
P/S
|
Development, research, testing and consulting services in the fields of pharmaceuticals, medical ... |
